This could be the next one that could make a good contribution...

This could be the next one that could make a good contribution to improvement of the share price.

"Long Neural COVID-19"The Company has continued discussions with targeted companies to explore interest inlicensing/commercialising our Long Covid- 19 Intellectual Property (IP), these discussions include an ongoing dialogue with a diagnostic company on a potential development collaboration. Australian patent application 2023900242 was lodged in February entitled “Biomarkers and uses thereof” following discussions with the diagnostic company that continue. We continue to work collaboratively with Professor Koralnik and with his input and his team’s assistance have prepared a scientific manuscript on some of the key research findings for submission to a high impact scientific journal. We are also exploring other potential collaborations including with Research Institutes trialling new therapies for subjects with NeuralLong Covid, with these groups expressing interest in accessing our IP for use as a companion diagnostic in the development of their potential treatments."